SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-005958
Filing Date
2020-01-13
Accepted
2020-01-13 08:16:50
Documents
47
Period of Report
2020-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d808722d8k.htm 8-K 19935
2 EX-99.1 d808722dex991.htm EX-99.1 21920
3 EX-99.2 d808722dex992.htm EX-99.2 30036
4 GRAPHIC g808722ex99_2s10g1.jpg GRAPHIC 190209
5 GRAPHIC g808722ex99_2s11g1.jpg GRAPHIC 403242
6 GRAPHIC g808722ex99_2s12g1.jpg GRAPHIC 276557
7 GRAPHIC g808722ex99_2s13g1.jpg GRAPHIC 207373
8 GRAPHIC g808722ex99_2s14g1.jpg GRAPHIC 139534
9 GRAPHIC g808722ex99_2s15g1.jpg GRAPHIC 117963
10 GRAPHIC g808722ex99_2s16g1.jpg GRAPHIC 126010
11 GRAPHIC g808722ex99_2s17g1.jpg GRAPHIC 426837
12 GRAPHIC g808722ex99_2s18g1.jpg GRAPHIC 330939
13 GRAPHIC g808722ex99_2s19g1.jpg GRAPHIC 158907
14 GRAPHIC g808722ex99_2s1g1.jpg GRAPHIC 461060
15 GRAPHIC g808722ex99_2s20g1.jpg GRAPHIC 218458
16 GRAPHIC g808722ex99_2s21g1.jpg GRAPHIC 308722
17 GRAPHIC g808722ex99_2s22g1.jpg GRAPHIC 177486
18 GRAPHIC g808722ex99_2s23g1.jpg GRAPHIC 250525
19 GRAPHIC g808722ex99_2s24g1.jpg GRAPHIC 276897
20 GRAPHIC g808722ex99_2s25g1.jpg GRAPHIC 267937
21 GRAPHIC g808722ex99_2s26g1.jpg GRAPHIC 235419
22 GRAPHIC g808722ex99_2s27g1.jpg GRAPHIC 196711
23 GRAPHIC g808722ex99_2s28g1.jpg GRAPHIC 212833
24 GRAPHIC g808722ex99_2s29g1.jpg GRAPHIC 216842
25 GRAPHIC g808722ex99_2s2g1.jpg GRAPHIC 701806
26 GRAPHIC g808722ex99_2s30g1.jpg GRAPHIC 190287
27 GRAPHIC g808722ex99_2s31g1.jpg GRAPHIC 187504
28 GRAPHIC g808722ex99_2s32g1.jpg GRAPHIC 279849
29 GRAPHIC g808722ex99_2s33g1.jpg GRAPHIC 305106
30 GRAPHIC g808722ex99_2s34g1.jpg GRAPHIC 219753
31 GRAPHIC g808722ex99_2s35g1.jpg GRAPHIC 206819
32 GRAPHIC g808722ex99_2s36g1.jpg GRAPHIC 162196
33 GRAPHIC g808722ex99_2s37g1.jpg GRAPHIC 230427
34 GRAPHIC g808722ex99_2s38g1.jpg GRAPHIC 300465
35 GRAPHIC g808722ex99_2s39g1.jpg GRAPHIC 178943
36 GRAPHIC g808722ex99_2s3g1.jpg GRAPHIC 375458
37 GRAPHIC g808722ex99_2s40g1.jpg GRAPHIC 308205
38 GRAPHIC g808722ex99_2s41g1.jpg GRAPHIC 225080
39 GRAPHIC g808722ex99_2s42g1.jpg GRAPHIC 514268
40 GRAPHIC g808722ex99_2s43g1.jpg GRAPHIC 383643
41 GRAPHIC g808722ex99_2s4g1.jpg GRAPHIC 520476
42 GRAPHIC g808722ex99_2s5g1.jpg GRAPHIC 349442
43 GRAPHIC g808722ex99_2s6g1.jpg GRAPHIC 238722
44 GRAPHIC g808722ex99_2s7g1.jpg GRAPHIC 302615
45 GRAPHIC g808722ex99_2s8g1.jpg GRAPHIC 328264
46 GRAPHIC g808722ex99_2s9g1.jpg GRAPHIC 385017
47 GRAPHIC g808722g0113041855091.jpg GRAPHIC 4296
  Complete submission text file 0001193125-20-005958.txt   16742003
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38541 | Film No.: 20522880
SIC: 2834 Pharmaceutical Preparations